MeVis Medical Solutions AG

XTRA:M3V Rapporto sulle azioni

Cap. di mercato: €44.4m

MeVis Medical Solutions Performance dei guadagni passati

Il passato criteri di controllo 2/6

MeVis Medical Solutions's earnings have been declining at an average annual rate of -7.1%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 0.2% per year. MeVis Medical Solutions's return on equity is 32.3%, and it has net margins of 32.6%.

Informazioni chiave

-7.1%

Tasso di crescita degli utili

-7.1%

Tasso di crescita dell'EPS

Healthcare Services Crescita del settore7.9%
Tasso di crescita dei ricavi-0.2%
Rendimento del capitale proprio32.3%
Margine netto32.6%
Prossimo aggiornamento sui guadagni30 Jan 2025

Aggiornamenti sulle prestazioni recenti

Recent updates

MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Nov 30
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

Mar 16
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Feb 14
MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

Feb 22
Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Feb 01
MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Ripartizione dei ricavi e delle spese

Come MeVis Medical Solutions guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

XTRA:M3V Ricavi, spese e utili (EUR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
31 Mar 2418610
31 Dec 2317510
30 Sep 2317510
30 Jun 2318610
31 Mar 2319610
31 Dec 2219710
30 Sep 2219810
30 Jun 2218700
31 Mar 2217600
31 Dec 2116500
30 Sep 2116500
30 Jun 2116500
31 Mar 2117500
31 Dec 2017500
30 Sep 2017600
30 Jun 2018710
31 Mar 2018710
31 Dec 1918700
30 Sep 1918800
30 Jun 1919800
31 Mar 1918900
31 Dec 1817810
30 Sep 1818800
30 Jun 1816710
31 Mar 1817410
31 Dec 1717310
30 Sep 1719610
30 Jun 1719510
31 Mar 1718710
31 Dec 1618810
30 Sep 1616710
30 Jun 1617710
31 Mar 1616610
31 Dec 1516710
30 Sep 1515310
30 Jun 1515310
31 Mar 1514410
31 Dec 1414410
30 Sep 1414400
30 Jun 1414400
31 Mar 1414400
31 Dec 1314400

Guadagni di qualità: M3V has high quality earnings.

Margine di profitto in crescita: M3V's current net profit margins (32.6%) are lower than last year (33.2%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: M3V's earnings have declined by 7.1% per year over the past 5 years.

Accelerare la crescita: M3V's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: M3V had negative earnings growth (-7.2%) over the past year, making it difficult to compare to the Healthcare Services industry average (7.1%).


Rendimento del capitale proprio

ROE elevato: M3V's Return on Equity (32.3%) is considered high.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate